Haru Kato

6.5k total citations
88 papers, 4.5k citations indexed

About

Haru Kato is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Haru Kato has authored 88 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Infectious Diseases, 35 papers in Epidemiology and 17 papers in Clinical Biochemistry. Recurrent topics in Haru Kato's work include Clostridium difficile and Clostridium perfringens research (51 papers), Microscopic Colitis (24 papers) and Viral gastroenteritis research and epidemiology (21 papers). Haru Kato is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (51 papers), Microscopic Colitis (24 papers) and Viral gastroenteritis research and epidemiology (21 papers). Haru Kato collaborates with scholars based in Japan, United States and Netherlands. Haru Kato's co-authors include Naoki Kato, Yoshichika Arakawa, Keigo Shibayama, Kunikazu Yamane, Naohiro Shibata, Kunitomo Watanabe, Tetsuya Yagi, Yohei Doi, Hiroshi Kurokawa and Satowa Suzuki and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Haru Kato

86 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haru Kato Japan 35 2.2k 1.6k 1.3k 1.1k 740 88 4.5k
Patricia Winokur United States 32 850 0.4× 1.5k 0.9× 1.6k 1.2× 681 0.6× 848 1.1× 95 4.0k
D.F. Sahm United States 28 1.6k 0.7× 974 0.6× 1.3k 0.9× 608 0.6× 452 0.6× 56 3.4k
Connie Clabots United States 39 2.2k 1.0× 2.0k 1.2× 1.8k 1.4× 610 0.6× 1.8k 2.5× 80 5.1k
Gunnar Skov Simonsen Norway 39 1.4k 0.6× 738 0.5× 1.3k 1.0× 758 0.7× 565 0.8× 114 3.7k
N.J. Legakis Greece 40 973 0.4× 1.5k 0.9× 2.6k 2.0× 1.1k 1.0× 1.1k 1.5× 187 5.1k
Panayotis T. Tassios Greece 25 985 0.4× 755 0.5× 2.1k 1.6× 805 0.8× 1.0k 1.4× 55 3.8k
F. W. Goldstein France 36 1.1k 0.5× 1.4k 0.9× 1.6k 1.2× 639 0.6× 441 0.6× 119 4.0k
A. Deplano Belgium 44 2.4k 1.1× 689 0.4× 1.3k 1.0× 1.8k 1.7× 725 1.0× 100 4.4k
Jacob Strahilevitz Israel 29 1.0k 0.5× 1.3k 0.8× 2.8k 2.1× 1.0k 1.0× 1.1k 1.4× 81 4.8k
Anthony Underwood United Kingdom 32 1.4k 0.6× 866 0.5× 758 0.6× 915 0.9× 902 1.2× 70 3.4k

Countries citing papers authored by Haru Kato

Since Specialization
Citations

This map shows the geographic impact of Haru Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haru Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haru Kato more than expected).

Fields of papers citing papers by Haru Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haru Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haru Kato. The network helps show where Haru Kato may publish in the future.

Co-authorship network of co-authors of Haru Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Haru Kato. A scholar is included among the top collaborators of Haru Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haru Kato. Haru Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niwa, Hidekazu, et al.. (2023). Clostridioides difficile infection in thoroughbred horses in Japan from 2010 to 2021. Scientific Reports. 13(1). 13099–13099. 5 indexed citations
3.
Senoh, Mitsutoshi, Masaaki Iwaki, Akihiko Yamamoto, et al.. (2018). Development of vaccine for Clostridium difficile infection using membrane fraction of nontoxigenic Clostridium difficile. Microbial Pathogenesis. 123. 42–46. 7 indexed citations
4.
Torio, Michiko, Kentaro Nakashima, Shunsuke Kanno, et al.. (2017). A childhood-onset intestinal toxemia botulism during chemotherapy for relapsed acute leukemia. Annals of Clinical Microbiology and Antimicrobials. 16(1). 61–61. 3 indexed citations
5.
Nishimura, Satoshi, Tadayuki Kou, Haru Kato, et al.. (2014). Fulminant pseudomembranous colitis caused by Clostridium difficile PCR ribotype 027 in a healthy young woman in Japan. Journal of Infection and Chemotherapy. 20(11). 729–731. 7 indexed citations
7.
Kato, Hideaki, et al.. (2009). Rapid analysis of Clostridium difficile strains recovered from hospitalized patients by using the slpA sequence typing system. Journal of Infection and Chemotherapy. 15(3). 199–202. 8 indexed citations
8.
Nakamura, Isao, et al.. (2004). Bacteremia Due to Clostridium difficile. Kansenshogaku zasshi. 78(12). 1026–1030. 1 indexed citations
9.
Yokoyama, Keiko, Yohei Doi, Kunikazu Yamane, et al.. (2003). Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. The Lancet. 362(9399). 1888–1893. 171 indexed citations
10.
Shibayama, Keigo, Kazunari Kamachi, Noriyo Nagata, et al.. (2003). A novel apoptosis‐inducing protein from Helicobacter pylori. Molecular Microbiology. 47(2). 443–451. 77 indexed citations
11.
Komatsu, Masaru, Haru Kato, Masanori Aihara, et al.. (2003). High Frequency of Antibiotic-Associated Diarrhea due to Toxin A-Negative, Toxin B-Positive Clostridium difficile in a Hospital in Japan and Risk Factors for Infection. European Journal of Clinical Microbiology & Infectious Diseases. 22(9). 525–529. 66 indexed citations
13.
Ueno, Kazue, Naoki Kato, & Haru Kato. (2002). The Status of Research on Anaerobes in Japan. Clinical Infectious Diseases. 35(s1). S54–S57. 3 indexed citations
14.
Kato, Haru, Naoki Kato, Shigetaka Katow, et al.. (1999). Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positiveClostridium difficilestrains. FEMS Microbiology Letters. 175(2). 197–203. 94 indexed citations
15.
Kubo, Katsutoshi, et al.. (1998). Effect of iodine tincture on rat oral mucosa.. Journal of Dental Research. 77. 754. 1 indexed citations
16.
Kato, Naoki, et al.. (1996). Comparison of In Vitro Activities of DU-6859a and Other Fluoroquinolones Against Japanese Isolates of Anaerobic Bacteria. Clinical Infectious Diseases. 23(Supplement_1). S31–S35. 14 indexed citations
17.
Kato, Naoki, et al.. (1995). The in vitro activity of pazufloxacin, a new orally quinolone, against anaerobic bacteria. 43. 47–53. 1 indexed citations
18.
Watanabe, Kunitomo, Kaori Tanaka, Naoki Kato, et al.. (1993). In vitro antibacterial activity of novel cephalosporin, cefozopran, against anaerobic bacteria. Chemotherapy. 41. 46–53. 1 indexed citations
19.
Kato, Naoki, et al.. (1993). Detection of ToxigenicClostridium difficilein Stool Specimens by the Polymerase Chain Reaction. The Journal of Infectious Diseases. 167(2). 455–458. 60 indexed citations
20.
Kato, Naoki, et al.. (1989). Gastric Microflora in Patients Receiving H2-Blocker. Kansenshogaku zasshi. 63(7). 726–731. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026